Login to Your Account

Amrad Drugs Dropped By GlaxoSmithKline, DevoCo

By Mark Lawson

Wednesday, April 10, 2002
SYDNEY, Australia - Melbourne-based Amrad Ltd. blamed a general industry shift into late-stage research projects on the decision by GlaxoSmithKline plc and DevoCo Pharmaceuticals Ltd. to separately abandon development work on Amrad compounds. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription